After being rejected twice, Horizon pushes Depomed to accept its €2.7Bn offer
Horizon Pharma is getting anxious and has offered the substantial amount of €2.7Bn to buy its…
Horizon Pharma is getting anxious and has offered the substantial amount of €2.7Bn to buy its…
AXON Neuroscience has completed a pioneer Phase I that offers new hope for millions of…
The progressive aging of the population in developed countries is turning Alzheimer into one of…
Alkermes reveals a new drug candidate, ALKS 7119, for treatment of Alzheimer’s agitation, depression and…
WHO? 23andMe, founded in 2006, is the leading personal genetics company dedicated to helping people…
AB Science SA, a pharmaceutical company specialized in research, development and marketing of protein kinase…
Stemedica International, a Stemedica Cell Technologies Inc. subsidiary developing stem cell therapies for Alzheimer’s disease…